bazedoxifene has been researched along with medroxyprogesterone acetate in 5 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 5,123 | 1,115 | 1,099 |
| Protein | Taxonomy | bazedoxifene (IC50) | medroxyprogesterone acetate (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.924 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
| Progesterone receptor | Homo sapiens (human) | 2.5081 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
| Androgen receptor | Homo sapiens (human) | 0.0061 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.924 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chines, AA; Komm, BS; Mirkin, S; Pan, K | 1 |
| Bushmakin, AG; Cappelleri, JC; Chines, AA; Mirkin, S; Pinkerton, JV; Racketa, J | 1 |
| Abraham, L; Chines, AA; Mirkin, S; Pan, K; Pinkerton, JV; Racketa, J; Ryan, KA | 1 |
| Archer, DF; Chines, AA; Harvey, JA; Lindsay, R; Mirkin, S; Pan, K; Pinkerton, JV | 1 |
| Abreu, P; Andrews, E; Kagan, R | 1 |
5 trial(s) available for bazedoxifene and medroxyprogesterone acetate
| Article | Year |
|---|---|
Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Selective Estrogen Receptor Modulators | 2013 |
Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.
Topics: Adult; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Models, Statistical; Placebos; Postmenopause; Sleep Wake Disorders; Treatment Outcome | 2014 |
Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
Topics: Double-Blind Method; Estrogens, Conjugated (USP); Female; Health Status; Hot Flashes; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Quality of Life; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2014 |
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Indoles; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2018 |